TRANSIENT NEONATAL PUSTULAR MELANOSIS

TRANSIENT NEONATAL PUSTULAR MELANOSIS was reported 8 times

TRANSIENT NEONATAL PUSTULAR MELANOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Cytochrome P450 3A Inhibitor [EPC] 6 0.0001
1 Protease Inhibitor [EPC] 3 0.0001
2 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0000
3 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3 0.0000
4 Macrolide Antimicrobial [EPC] 1 0.0000